Intervention Review

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia

  1. Pranav S. Garimella1,
  2. Howard A Fink2,
  3. Roderick MacDonald3,
  4. Timothy J Wilt3,*

Editorial Group: Cochrane Urology Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 15 JUN 2009

DOI: 10.1002/14651858.CD007360.pub2


How to Cite

Garimella PS, Fink HA, MacDonald R, Wilt TJ. Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD007360. DOI: 10.1002/14651858.CD007360.pub2.

Author Information

  1. 1

    John H. Stroger Hospital of Cook County, Chicago, Illinois, USA

  2. 2

    VA Medical Center, Geriatric Research Education and Clinical Center, Box 11G, Minneapolis, Minnesota, USA

  3. 3

    VAMC, General Internal Medicine (111-0), Minneapolis, MN, USA

*Timothy J Wilt, General Internal Medicine (111-0), VAMC, One Veterans Drive, Minneapolis, MN, 55417, USA. Tim.Wilt@med.va.gov.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH